一系列新型虫草素衍生物的设计、合成及其抗肿瘤活性研究

doi:10.5246/jcps.2022.01.006

中国药学(英文版) ›› 2022, Vol. 31 ›› Issue (1): 55-67.DOI: 10.5246/jcps.2022.01.006

一系列新型虫草素衍生物的设计、合成及其抗肿瘤活性研究

蒋丽娟², 曹婷婷¹, 杨诺一¹, 李颖¹, 董林¹, 尹述凡¹^,^*()

1. 四川大学化学学院, 四川成都 610064
2. 广西民族大学化学化工学院; 广西多糖材料与改性重点实验室, 广西南宁 530008

收稿日期:2021-07-17 修回日期:2021-08-11 接受日期:2021-09-16 出版日期:2022-01-12 发布日期:2022-01-13
通讯作者: 尹述凡
作者简介:
+ Tel.: +86-13908005096, E-mail: chuandayouji217@163.com
基金资助:
Research Basic Ability Enhancement Project of Young and Middle-aged Teachers in Guangxi Universities (Grant No. 2019KY0166) and the Project of Guangxi University for Nationalities (Grant No. 2018MDYB006, 2018XJGY46).

Design, synthesis, and biological evaluation of a series of novel cordycepin derivatives

Lijuan Jiang², Tingting Cao¹, Ruoyi Yang¹, Ying Li¹, Lin Dong¹, Shufan Yin¹^,^*()

1 College of Chemistry, Sichuan University, Chengdu 610064, Sichuan, China
2 School of Chemistry and Chemical Engineering, Guangxi University for Nationalities; Guangxi Key Laboratory for Polysaccharide Materials and Modifications, Nanning 530008, China

Received:2021-07-17 Revised:2021-08-11 Accepted:2021-09-16 Online:2022-01-12 Published:2022-01-13
Contact: Shufan Yin

摘要/Abstract

摘要：

本研究合成了一系列6位嘌呤环取代苯磺酰胺基团的虫草素衍生物, 并对其进行了抗肿瘤活性研究。我们对虫草素衍生物具有抗肿瘤活性的药效结构部分做了初步探讨。在MDA-MB-231和A549细胞的抗增殖活性实验中, 苯环上有4-甲基和4-硝基取代基的化合物活性优于先导化合物。然而, 在HeLa细胞的抗增殖活性实验中, 4-甲氧基苯、2-氧吲哚啉基团化合物和乙烯基的化合物活性比先导化合物表现出更显著的活性。其中, 具有4-溴取代基的化合物3e和3f对MDA-MB-231、A549和HeLa细胞的增殖均具有很高的抑制活性, 这意味着它具有进一步开发和应用的潜力。

关键词: 虫草素, 衍生物, 合成, 生物活性研究

Abstract:

: In this study, a novel series of cordycepin derivatives with benzenesulfonamido groups at the 6-position of the purine ring were synthesized and their antitumor activity was evaluated. We revealed the structural moieties of the cordycepin analogs that were required for antitumor activity. Among all the target compounds, those with 4-methyl and 4-nitro substituents on the benzene ring displayed better activity than the lead compound in antiproliferative activity experiments using MDA-MB-231 and A549 cells. However, compounds with 4-methoxybenzene and 2-oxoindoline groups and ethylene spacers displayed more significant activity than the lead compound in antiproliferative activity experiments using HeLa cells. In particular, a compound with a 4-bromo substituent and an ethylene spacer displayed very high inhibitory activity against the proliferation of MDA-MB-231, A549, and HeLa cells, suggesting that it had the potential for further development and application.

Key words: Cordycepin, Derivatives, Synthesis, Biological activity research

Supporting:

蒋丽娟, 曹婷婷, 杨诺一, 李颖, 董林, 尹述凡. 一系列新型虫草素衍生物的设计、合成及其抗肿瘤活性研究[J]. 中国药学(英文版), 2022, 31(1): 55-67.

Lijuan Jiang, Tingting Cao, Ruoyi Yang, Ying Li, Lin Dong, Shufan Yin. Design, synthesis, and biological evaluation of a series of novel cordycepin derivatives[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(1): 55-67.

图/表 4

Scheme 1. Synthesis of compounds 3a, 3c, 3e, 3g, and 3i. Reagents and conditions: (a) DMF, NaH, rt, 1 h.

Table 1. Structures and yields of target compounds.

Scheme 2. Synthesis of compounds 3b, 3d, 3f, 3h, 3j, and 3k. Reagents and conditions: (a) THF, NaHCO3, 60 oC, 6 h; (b) NaH, DMF, 1, rt–120 oC; (c) ClHSO3, 30–68 oC, 1.5 h.

Table 2. Effect of cordycepin and target compounds in terms of inhibitory activity against the proliferation of MDA-MB-231, A549, and HeLa cells.

参考文献 21

[1]	Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J. Clin. 2018, 68, 394–424.
[2]	Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2019. CA: A Cancer J. Clin. 2019, 69, 7–34.
[3]	Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J. Clin. 2018, 68, 394–424.
[4]	Yu, H.M.; Wang, B.S.; Huang, S.C.; Duh, P.D. Comparison of protective effects between cultured Cordyceps militaris and natural Cordyceps sinensis against oxidative damage. J. Agric. Food Chem. 2006, 54, 3132–3138.
[5]	Tsai, Y.J.; Lin, L.C.; Tsai, T.H. Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in rat. J. Agric. Food Chem. 2010, 58, 4638–4643.
[6]	Chen, Y.; Chen, Y.C.; Lin, Y.T.; Huang, S.H.; Wang, S.M. Cordycepin induces apoptosis of CGTH W-2 thyroid carcinoma cells through the Calcium-Calpain-Caspase 7-PARP pathway. J. Agric. Food Chem. 2010, 58, 11645–11652.
[7]	Aman, S.; Anderson, D.J.; Connolly, T.J.; Crittall, A.J.; Ji, G.J. From adenosine to 3’-deoxyadenosine: development and scale up. Org. Process. Res. Dev. 2000, 4, 601–605.
[8]	Vodnala, S.K.; Lundbäck, T.; Yeheskieli, E.; Sjöberg, B.; Gustavsson, A.L.; Svensson, R.; Olivera, G.C.; Eze, A.A.; de Koning, H.P.; Hammarström, L.G.J.; Rottenberg, M.E. Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis. J. Med. Chem. 2013, 56, 9861–9873.
[9]	Vodnala, S.K.; Lundbäck, T.; Yeheskieli, E.; Sjöberg, B.; Gustavsson, A.L.; Svensson, R.; Olivera, G.C.; Eze, A.A.; de Koning, H.P.; Hammarström, L.G.J.; Rottenberg, M.E. Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis. J. Med. Chem. 2013, 56, 9861–9873.
[10]	Bouchain, G.; Leit, S.; Frechette, S.; Khalil, E.A.; Lavoie, R.; Moradei, O.; Woo, S.H.; Fournel, M.; Yan, P.T.; Kalita, A.; Trachy-Bourget, M.C.; Beaulieu, C.; Li, Z.M.; Robert, M.F.; MacLeod, A.R.; Besterman, J.M.; Delorme, D. Development of potential antitumor agents. synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors. J. Med. Chem. 2003, 46, 820–830.
[11]	Morimoto, H.; Shimadzu, H.; Kushiyama, E.; Kawanishi, H.; Hosaka, T.; Kawase, Y.; Yasuda, K.; Kikkawa, K.; Yamauchi-Kohno, R.; Yamada, K. Potent and Selective ET-A Antagonists. 1. Syntheses and Structure–Activity Relationships of N-(6-(2-(Aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide Derivatives. J. Med. Chem. 2001, 44, 3355–3368.
[12]	Noreljaleel, A.E.M.; Wilhelm, A.; Bonnet, S.L.; van der Westhuizen, J.H. Synthesis and bioactivity of reduced chalcones containing sulfonamide side chains. J. Nat. Prod. 2018, 81, 41–48.
[13]	Sato, K.; Takahagi, H.; Yoshikawa, T.; Morimoto, S.; Takai, T.; Hidaka, K.; Kamaura, M.; Kubo, O.; Adachi, R.; Ishii, T.; Maki, T.; Mochida, T.; Takekawa, S.; Nakakariya, M.; Amano, N.; Kitazaki, T. Discovery of a novel series of N-phenylindoline-5-sulfonamide derivatives as potent, selective, and orally bioavailable acyl CoA: monoacylglycerol acyltransferase-2 inhibitors. J. Med. Chem. 2015, 58, 3892–3909.
[14]	Yang, P.; Wang, L.P.; Feng, R.T.; Almehizia, A.A.; Tong, Q.; Myint, K.Z.; Ouyang, Q.; Alqarni, M.H.; Wang, L.R.; Xie, X.Q. Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors: discovery, optimization, and biological evaluation. J. Med. Chem. 2013, 56, 2045–2058.
[15]	Tsai, Y.J.; Lin, L.C.; Tsai, T.H. Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in rat. J. Agric. Food Chem. 2010, 58, 4638–4643.
[16]	Bi, Y.M.; Li, H.; Yi, D.Z.; Sun, Y.X.; Bai, Y.; Zhong, S.; Song, Y.; Zhao, G.; Chen, Y. Cordycepin augments the chemosensitivity of human glioma cells to temozolomide by activating AMPK and inhibiting the AKT signaling pathway. Mol. Pharm. 2018, 15, 4912–4925.
[17]	Wen, Z.X.; Du, X.F.; Meng, N.; Li, Y.J.; Mi, R.; Li, X.J.; Sun, Y.X.; Ma, S.H.; Li, S.Y. Tussah silkmoth pupae improve anti-tumor properties of Cordyceps militaris (L.) Link by increasing the levels of major metabolite cordycepin. RSC Adv. 2019, 9, 5480–5491.
[18]	Khuntawee, W.; Amornloetwattana, R.; Vongsangnak, W.; Namdee, K.; Yata, T.; Karttunen, M.; Wong-Ekkabut, J. In silico and in vitro design of cordycepin encapsulation in liposomes for colon cancer treatment. RSC Adv. 2021, 11, 8475–8484.
[19]	Singpoonga, N.; Rittiron, R.; Seang-On, B.; Chaiprasart, P.; Bantadjan, Y. Determination of adenosine and cordycepin concentrations in cordyceps militaris fruiting bodies using near-infrared spectroscopy. ACS Omega. 2020, 5, 27235–27244.
[20]	Guianvarc'H, D.; Duca, M.; Boukarim, C.; Kraus-Berthier, L.; Léonce, S.; Pierré, A.; Pfeiffer, B.; Renard, P.; Arimondo, P.B.; Monneret, C.; Dauzonne, D. Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin. J. Med. Chem. 2004, 47, 2365–2374.
[21]	Morimoto, H.; Shimadzu, H.; Kushiyama, E.; Kawanishi, H.; Hosaka, T.; Kawase, Y.; Yasuda, K.; Kikkawa, K.; Yamauchi-Kohno, R.; Yamada, K. Potent and Selective ET-A Antagonists. 1. Syntheses and Structure–Activity Relationships of N-(6-(2-(Aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide Derivatives. J. Med. Chem. 2001, 44, 3355–3368.

一系列新型虫草素衍生物的设计、合成及其抗肿瘤活性研究

Design, synthesis, and biological evaluation of a series of novel cordycepin derivatives

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 4

参考文献 21

相关文章 15

编辑推荐

Metrics

本文评价

[1]	朱玉霞, 张玲建, 胡懿鸣, 刘卫华, 关丽萍, 林琳. 海洋中药厚藤中柚皮素(naringenin)衍生物合成及胆碱酯酶抑制活性研究[J]. 中国药学(英文版), 2023, 32(8): 636-644.
[2]	范博, 杨笑, 胡爽. 涡旋辅助-可切换型溶剂液相微萃取用于中药样品中肉桂酸衍生物的分析[J]. 中国药学(英文版), 2023, 32(7): 551-559.
[3]	蔡粟茜, 张可锋, 蔡小华. 岩白菜素: 一种通用易得的生物活性修饰前体[J]. 中国药学(英文版), 2023, 32(5): 333-350.
[4]	孙遨, 李紫鹏, 刘婷, 孟祥豹, 李树春, 李中军. Kdo化学合成方法改进[J]. 中国药学(英文版), 2022, 31(2): 97-107.
[5]	吕慧婕, 许拓, 彭俊, 罗刚, 何剑琴, 杨丝丝, 张天成, 奉水东, 凌宏艳. 氢杨梅素改善高脂饮食诱导的肥胖小鼠肝脏脂肪沉积及机制[J]. 中国药学(英文版), 2022, 31(11): 824-839.
[6]	刘玥华, 薛章勤, 魏剑明, 魏若梦, 殷宝栋, 刘爱芹. 奥帕膦酸钠的药物合成及活性研究[J]. 中国药学(英文版), 2022, 31(11): 883-892.
[7]	许士琪, 朱礼岩, 郝超, 刘文倩, 陈成龙, 陈泳怡, 刘爱芹. 一种新型含氨基酸基团替加氟前药的合成及其抗肿瘤活性评价[J]. 中国药学(英文版), 2021, 30(9): 743-753.
[8]	北京大学药学院天然药物及仿生药物国家重点实验室. 环肽分子生物合成-马明团队发现第一个催化异构化/环化双功能硫酯酶并解析其晶体结构[J]. 中国药学(英文版), 2021, 30(9): 778-779.
[9]	张慧文, 许海燕, 张玉, 马超美. A型原花青素衍生物的制备、抗氧化和α-葡萄糖苷酶抑制活性研究[J]. 中国药学(英文版), 2021, 30(4): 280-288.
[10]	蔡雪妮, 富戈, Martin Lepšík, Emanuele Paci, 郭媛, 李中军, 李庆. 一系列新型同形及杂合糖簇的合成及DC-SIGN结合活性研究[J]. 中国药学(英文版), 2021, 30(11): 859-873.
[11]	周北斗, 李佳莉, 黄堡城, 俞紫涵, 马泽通, 阮志鹏, 蔡其洪, 胡栋宝. 苯甲酸苯酯类化合物的合成与生物活性调查[J]. 中国药学(英文版), 2021, 30(11): 874-882.
[12]	李茜茜, 刘乾, 盛涛, 刘俊义, 王孝伟. 吡啶酮类HIV-1非核苷逆转录酶抑制剂: 组合优化设计策略[J]. 中国药学(英文版), 2020, 29(2): 79-89.
[13]	颜婉君, 李文明, 熊德彩, 叶新山. 氨基甲酸酯类唾液酸转移酶抑制剂的设计、合成与活性评价[J]. 中国药学(英文版), 2020, 29(1): 29-44.
[14]	张中义, 王翰轩, 王贵阳, 马学洋, 刘谈, 耿彤彤, 孙晓旭, 杨东辉, 董甦伟, 马明. 环肽WS9326A生物合成中硫酯酶两个底物类似物的合成[J]. 中国药学(英文版), 2019, 28(9): 605-614.
[15]	杨绪朋, 仰浈臻, 张泸, 孙琪, 齐宪荣. 采用无表面活性剂体系合成不同形貌金纳米星[J]. 中国药学(英文版), 2019, 28(9): 641-649.